COVID 19 treatment through RNA interference

المؤلفون

  • Yaseen Hussain College of Pharmaceutical Sciences, Soochow University, China
  • Amjad Hayat Khan Department of Allied Health Sciences, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Fazlullah Khan Faculty of pharmacy, Capital University of Science and Technology, Islamabad, Pakistan
  • Arbaz Ul Hussan Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Mubashir Kabir Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Iftikhar Ali Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Muhammad Sajjad Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Ayesha Sadaf Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Javeria Mukhtar Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Faiza Hassan Department of pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan

DOI:

https://doi.org/10.53576/bashir.003.01.0044

الكلمات المفتاحية:

Covid-19، siRNA، SARS-CoV-2، proteolytic enzymes، open reading frames، viral RNA-polymerase

الملخص

Not attempted because its a short commentary.

التنزيلات

منشور

2022-12-12

إصدار

مجلد 3 عدد 1 (2022): J. Bashir Inst. Health Sci.

القسم

Commentry

الرخصة

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). You are free to share, copy, and adapt this material for any purpose, including commercial use, as long as you give appropriate credit to the original author(s), provide a link to the license, and indicate if changes were made.